Prognostic Significance of Complications after Curative Surgery for Gastric Cancer

被引:0
|
作者
Takeshi Kubota
Naoki Hiki
Takeshi Sano
Shogo Nomura
Souya Nunobe
Koshi Kumagai
Susumu Aikou
Ryohei Watanabe
Toshiyuki Kosuga
Toshiharu Yamaguchi
机构
[1] Cancer Institute Hospital,Department of Gastroenterological Surgery
[2] Japanese Foundation for Cancer Research,Department of Biostatistic
[3] National Cancer Center,undefined
来源
Annals of Surgical Oncology | 2014年 / 21卷
关键词
Gastric Cancer; Overall Survival; Anastomotic Leakage; Laparoscopic Gastrectomy; Gray Model;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:891 / 898
页数:7
相关论文
共 50 条
  • [31] Relation of INHBA Gene Expression to Outcomes in Gastric Cancer after Curative Surgery
    Oshima, Takashi
    Yoshihara, Kazue
    Aoyama, Toru
    Hasegawa, Shinich
    Sato, Tsutomu
    Yamamoto, Naoto
    Akito, Nozaki
    Shiozawa, Manabu
    Yoshikawa, Takaki
    Numata, Kazushi
    Rino, Yasushi
    Kunisaki, Chikara
    Tanaka, Katsuaki
    Akaike, Makoto
    Imada, Toshio
    Masuda, Munetaka
    ANTICANCER RESEARCH, 2014, 34 (05) : 2303 - 2309
  • [32] Prognostic Factors for Survival in Patients with Hepatic Recurrence After Curative Resection of Gastric Cancer
    Si-Eun Hwang
    Doo-Hyun Yang
    Chan-Young Kim
    World Journal of Surgery, 2009, 33 : 1468 - 1472
  • [33] The Glasgow Prognostic Score Before Curative Resection May Predict Postoperative Complications in Patients with Gastric Cancer
    Shimoda, Yota
    Fujikawa, Hirohito
    Komori, Keisuke
    Watanabe, Hayato
    Takahashi, Kosuke
    Kano, Kazuki
    Yamada, Takanobu
    Shiozawa, Manabu
    Morinaga, Soichiro
    Katsumata, Kenji
    Tsuchida, Akihiko
    Ogata, Takashi
    Oshima, Takashi
    JOURNAL OF GASTROINTESTINAL CANCER, 2022, 53 (04) : 908 - 914
  • [34] Prevalence and Clinical Implications of Ascites in Gastric Cancer Patients after Curative Surgery
    Lee, Ju-Hee
    Kwon, Sung-Joon
    Kim, Mimi
    Kang, Bo-Kyeong
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
  • [35] The Glasgow Prognostic Score Before Curative Resection May Predict Postoperative Complications in Patients with Gastric Cancer
    Yota Shimoda
    Hirohito Fujikawa
    Keisuke Komori
    Hayato Watanabe
    Kosuke Takahashi
    Kazuki Kano
    Takanobu Yamada
    Manabu Shiozawa
    Soichiro Morinaga
    Kenji Katsumata
    Akihiko Tsuchida
    Takashi Ogata
    Takashi Oshima
    Journal of Gastrointestinal Cancer, 2022, 53 : 908 - 914
  • [36] Prognostic significance of preoperative osteopenia on outcomes after gastrectomy for gastric cancer
    Fukushima, Naoko
    Tsuboi, Kazuto
    Nyumura, Yuya
    Hoshino, Masato
    Masuda, Takahiro
    Suzuki, Toshimasa
    Kajimoto, Tetsuya
    Yano, Fumiaki
    Eto, Ken
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2023, 7 (02): : 255 - 264
  • [37] Prognostic significance of cyclin A in gastric cancer
    Mrena, Johanna
    Wiksten, Jan-Patrik
    Kokkola, Arto
    Nordling, Stig
    Haglund, Caj
    Ristimaki, Ari
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (08) : 1897 - 1901
  • [38] Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy
    Aydin, D.
    Bilici, A.
    Yavuzer, D.
    Kefeli, U.
    Tan, A.
    Ercelep, O.
    Mert, A.
    Yuksel, S.
    Ozcelik, M.
    Isik, D.
    Surmeli, H.
    Odabasi, H.
    Aliustaoglu, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (08) : 604 - 611
  • [39] Prognostic significance of metastatic lymph node ratio in patients with gastric cancer after curative gastrectomy: a single-center retrospective study
    He, Zhipeng
    Li, Dongchang
    Xu, Yunfeng
    Wang, Haoran
    Gao, Junpeng
    Zhang, Zhigong
    Chen, Ke
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (07) : 832 - 841
  • [40] Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy
    D. Aydin
    A. Bilici
    D. Yavuzer
    U. Kefeli
    A. Tan
    O. Ercelep
    A. Mert
    S. Yuksel
    M. Ozcelik
    D. Isik
    H. Surmeli
    H. Odabasi
    M. Aliustaoglu
    Clinical and Translational Oncology, 2015, 17 : 604 - 611